Literature DB >> 15471987

Visualization of a functionally enhanced GFP-tagged galanin R2 receptor in PC12 cells: constitutive and ligand-induced internalization.

Sheng Xia1, Svend Kjaer, Kang Zheng, Ping-Sheng Hu, Li Bai, Jun-Yong Jia, Rudolf Rigler, Aladdin Pramanik, Tao Xu, Tomas Hökfelt, Zhi-Qing David Xu.   

Abstract

Trafficking of the galanin R2 receptor (GALR2) fused with enhanced GFP (EGFP) was studied by using confocal fluorescence microscopy. The fusion protein was predominantly localized on the plasma membrane with some intracellular fluorescent structures (vesicles), mainly in the perinuclear region. Incubation with galanin resulted in a concentration-dependent increase in intracellular Ca2+ concentration levels, suggesting that the GALR2-EGFP conjugate is functional. After blocking endocytosis with methyl-beta-cyclodextrin GALR2-EGFP expression was increased on the surface and decreased in the cytoplasm. Blocking endocytic recycling with monensin caused an increase of intracellular GALR2-EGFP accumulation and a decrease of fluorescence on the plasma membrane. GALR2-EGFP on the plasma membrane was internalized within 5-10 min after treatment with galanin or AR-M1896, a selective GALR2 agonist, with a dramatic reduction in plasma membrane localization and appearance in intracellular vesicles. Neither M35 nor M40, two galanin analogues with putative antagonistic action, prevented GALR2 agonist-induced internalization of GALR2-EGFP, suggesting that they are not antagonists at this receptor under the present circumstances. Galanin stimulation at low temperature caused GALR2-EGFP aggregation and clustering on the surface but no translocation to cytoplasm. After coincubation with galanin the GALR2-EGFP was colocalized with internalized Texas red-transferrin, a marker of the clathrin endocytic pathway. Hyperosmotic sucrose inhibited internalization of GALR2-EGFP. Taken together these findings indicate that GALR2 undergoes constitutive endocytosis and recycling and that both ligand-independent and ligand-dependent internalization use the clathrin-dependent endocytic recycling pathway.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15471987      PMCID: PMC524062          DOI: 10.1073/pnas.0406571101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  49 in total

Review 1.  Using green fluorescent proteins to study G-protein-coupled receptor localization and trafficking.

Authors:  L Kallal; J L Benovic
Journal:  Trends Pharmacol Sci       Date:  2000-05       Impact factor: 14.819

Review 2.  Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling.

Authors:  S S Ferguson
Journal:  Pharmacol Rev       Date:  2001-03       Impact factor: 25.468

3.  Effects of galanin receptor agonists on locus coeruleus neurons.

Authors:  X Ma; Y G Tong; R Schmidt; W Brown; K Payza; L Hodzic; C Pou; C Godbout; T Hökfelt; Z Q Xu
Journal:  Brain Res       Date:  2001-11-16       Impact factor: 3.252

4.  Constitutive internalization of constitutively active agiotensin II AT(1A) receptor mutants is blocked by inverse agonists.

Authors:  Stéphanie Miserey-Lenkei; Charles Parnot; Sabine Bardin; Pierre Corvol; Eric Clauser
Journal:  J Biol Chem       Date:  2001-11-29       Impact factor: 5.157

Review 5.  Endocytosis of G protein-coupled receptors: roles of G protein-coupled receptor kinases and beta-arrestin proteins.

Authors:  Audrey Claing; Stéphane A Laporte; Marc G Caron; Robert J Lefkowitz
Journal:  Prog Neurobiol       Date:  2002-02       Impact factor: 11.685

Review 6.  Role of endocytosis in signalling and regulation of G-protein-coupled receptors.

Authors:  M von Zastrow
Journal:  Biochem Soc Trans       Date:  2001-08       Impact factor: 5.407

7.  Trafficking of M(2) muscarinic acetylcholine receptors.

Authors:  A G Roseberry; M M Hosey
Journal:  J Biol Chem       Date:  1999-11-19       Impact factor: 5.157

8.  Role of the thrombin receptor's cytoplasmic tail in intracellular trafficking. Distinct determinants for agonist-triggered versus tonic internalization and intracellular localization.

Authors:  M J Shapiro; J Trejo; D Zeng; S R Coughlin
Journal:  J Biol Chem       Date:  1996-12-20       Impact factor: 5.157

9.  The human cytomegalovirus US28 protein is located in endocytic vesicles and undergoes constitutive endocytosis and recycling.

Authors:  A Fraile-Ramos; T N Kledal; A Pelchen-Matthews; K Bowers; T W Schwartz; M Marsh
Journal:  Mol Biol Cell       Date:  2001-06       Impact factor: 4.138

10.  Receptor subtype-specific pronociceptive and analgesic actions of galanin in the spinal cord: selective actions via GalR1 and GalR2 receptors.

Authors:  H X Liu; P Brumovsky; R Schmidt; W Brown; K Payza; L Hodzic; C Pou; C Godbout; T Hökfelt
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-31       Impact factor: 11.205

View more
  17 in total

1.  Visualizing odorant receptor trafficking in living cells down to the single-molecule level.

Authors:  V Jacquier; M Prummer; J-M Segura; H Pick; H Vogel
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-15       Impact factor: 11.205

2.  Galanin decreases proliferation of PC12 cells and induces apoptosis via its subtype 2 receptor (GalR2).

Authors:  R Tofighi; B Joseph; S Xia; Z-Q D Xu; B Hamberger; T Hökfelt; S Ceccatelli
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-12       Impact factor: 11.205

3.  Phospholipase C{beta}3 in mouse and human dorsal root ganglia and spinal cord is a possible target for treatment of neuropathic pain.

Authors:  Tie-Jun Sten Shi; Su-Xing Leslie Liu; Henrik Hammarberg; Masahiko Watanabe; Zhi-Qing David Xu; Tomas Hökfelt
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-09       Impact factor: 11.205

4.  Species- and cell type-specific interactions between CD47 and human SIRPalpha.

Authors:  Shyamsundar Subramanian; Ranganath Parthasarathy; Shamik Sen; Eric T Boder; Dennis E Discher
Journal:  Blood       Date:  2005-11-15       Impact factor: 22.113

5.  Global ablation of the mouse Rab11a gene impairs early embryogenesis and matrix metalloproteinase secretion.

Authors:  Shiyan Yu; Ghassan Yehia; Juanfei Wang; Ewa Stypulkowski; Ryotaro Sakamori; Ping Jiang; Berenice Hernandez-Enriquez; Tracy S Tran; Edward M Bonder; Wei Guo; Nan Gao
Journal:  J Biol Chem       Date:  2014-09-30       Impact factor: 5.157

6.  PIP2 signaling in lipid domains: a critical re-evaluation.

Authors:  Jacco van Rheenen; Eskeatnaf Mulugeta Achame; Hans Janssen; Jero Calafat; Kees Jalink
Journal:  EMBO J       Date:  2005-04-21       Impact factor: 11.598

7.  Disease-causing mutation in PKR2 receptor reveals a critical role of positive charges in the second intracellular loop for G-protein coupling and receptor trafficking.

Authors:  Zhen Peng; Yong Tang; Hunjin Luo; Fang Jiang; Jiannan Yang; Lin Sun; Jia-Da Li
Journal:  J Biol Chem       Date:  2011-03-16       Impact factor: 5.157

8.  Amino acid residues critical for endoplasmic reticulum export and trafficking of platelet-activating factor receptor.

Authors:  Nobuaki Hirota; Daisuke Yasuda; Tomomi Hashidate; Teruyasu Yamamoto; Satoshi Yamaguchi; Teruyuki Nagamune; Takahide Nagase; Takao Shimizu; Motonao Nakamura
Journal:  J Biol Chem       Date:  2009-12-10       Impact factor: 5.157

9.  Postendocytotic traffic of the galanin R1 receptor: a lysosomal signal motif on the cytoplasmic terminus.

Authors:  Sheng Xia; Xing-Peng Dun; Ping-Sheng Hu; Svend Kjaer; Kang Zheng; Yu Qian; Christina Solén; Tao Xu; Bertil Fredholm; Tomas Hökfelt; Zhi-Qing David Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-02       Impact factor: 11.205

10.  Identification and characterization of distinct C-terminal domains of the human hydroxycarboxylic acid receptor-2 that are essential for receptor export, constitutive activity, desensitization, and internalization.

Authors:  Guo Li; Qi Zhou; Yena Yu; Linjie Chen; Ying Shi; Jiansong Luo; Jeffrey Benovic; Jianxin Lu; Naiming Zhou
Journal:  Mol Pharmacol       Date:  2012-09-07       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.